Articles

Protecting the skin from the sun should be considered a year-round necessity because our skin is constantly exposed to the sun’s ultraviolet rays and is thus susceptible to melanoma. Read More ›

Sorafenib has become the first drug in years to prove effective in the treatment of differentiated thyroid cancer (DTC) that has become resistant to radioactive iodine (RAI), according to phase 3 study results reported at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting. Read More ›

Read More ›

In November 2011, Mission Health, located in Asheville, North Carolina, opened the Mission SECU Cancer Center to provide comprehensive cancer care that includes state-of-the-art technology and comfortable, effective treatment delivery. Read More ›

The 2013 American Society of Clinical Oncology (ASCO) Annual Meeting brought approximately 30,000 cancer specialists to Chicago, Illinois, from May 31 to June 4, 2013. Read More ›

Updates to the Clinical Practice Guidelines of the National Comprehensive Cancer Network (NCCN) were presented at the NCCN’s 2013 Annual Conference. Read More ›

For years, the cancer research community has pushed for the use of surrogate end points in clinical trials as a means of hastening the drug approval process. Read More ›

MMA talks about how much she appreciates her oncology nurses, but notes that there are some things they have not done. Read More ›

Noncervical human papilloma virus (HPV)–associated oral and anal cancers are on the rise in the United States in men and women. Read More ›

The thyroid gland, though relatively small, plays a large role in the function of the body. Read More ›